Under the guidance of Dr Fiona Dziegiel, we are seeking to recruit a Scientific Writer to produce clear, accurate and engaging scientific content to showcase the innovative research of the Centres for Protein Degradation and Cancer Drug Discovery to enhance external visibility.
About you
The successful candidate must have:
1. PhD in life sciences, health sciences, or related field
2. Excellent writing skills with the ability to translate complex scientific concepts into clear and engaging content
3. Experience writing manuscripts and social media content
4. Excellent organisational skills, flexibility and the ability to manage changing priorities
5. Ability to work independently and collaboratively
The postholder will support the development, editing and management of scientific documents including manuscripts, reports, presentations and material for grant applications. They will coordinate data collection, maintain organised information systems, and manage online and social media content to strengthen the Centres’ visibility. Working closely with scientists, project managers, and the professional services teams, the Scientific Writer will ensure timely, effective communication of research activities and key developments, helping to advance the Centres’ missions to discover and develop innovative cancer therapeutics.
Department Information
The Centre for Protein Degradation
The ICR established the Centre for Protein Degradation (CPD) in 2022 to accelerate targeted protein degradation-based drug discovery – an innovative approach utilising drug-induced degradation of harmful proteins via the cell’s endogenous protein disposal system. Our aim is to discover novel molecular glue degraders and PROTACs for the treatment of the most challenging cancers. Based at the ICR’s Centre for Cancer Drug Discovery, the CPD benefits from state-of-the-art drug discovery platforms – biology, medicinal and in silico chemistry, biophysics, structural biology, proteomics, bioinformatics, as well as strong cancer biology and clinical expertise within the wider ICR and the Royal Marsden Hospital. We also have established collaborations with biotechnology companies and the pharmaceutical industry.
The Centre for Cancer Drug Discovery
The Division of Cancer Therapeutics has an unrivalled track record at discovering novel cancer treatments for the personalised treatment of cancer. Within the Division, the Centre for Cancer Drug Discovery (CCDD) is a multidisciplinary 'bench to bedside' centre, comprising 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. We are one of the largest academic cancer drug discovery groups in the world and, together with our collaborators, have discovered 21 preclinical development candidates, 13 of which have been progressed to clinical evaluation, many with our partners in the ICR/Royal Marsden Drug Development Unit. Our drug abiraterone (Zytiga) has been approved in the US, Canada and Europe for late-stage prostate cancer.
The CCDD’s mission is to develop personalised medicines by translating information from the cancer genome and cancer biology into drugs for patient benefit. We implement innovative drug discovery technologies, discover novel mechanism-based drugs, and develop these as rapidly as possible from the laboratory through to hypothesis-testing early clinical trials. We publish our work extensively and have a large network of collaborations with academia, biotechnology companies, and the pharmaceutical industry. Our teams are dedicated to the discovery of small molecule drug candidates, and to the development of high-quality chemical probes to enable new cancer biology research. The Division of Cancer Therapeutics is based in state-of-the art laboratories in the Centre for Cancer Drug Discovery building, opened in 2020 on the ICR Sutton campus.
What we offer
6. A dynamic and supportive research environment
7. Access to state-of-the-art facilities and professional development opportunities
8. Collaboration with leading researchers in the field
9. Competitive salary and pension